Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Science and Technology, Taxation and Finance
|
Communicating with government officials about additional government funding for the life sciences sector.
|
Grant, Contribution or Other Financial Benefit
|
End date of the last completed financial year: 2026-03-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Prairies Economic Development Canada (PrairiesCan) | $56,588,200.00 | No |
Address:
10230 Jasper Avenue
Suite 4000
Edmonton, AB T5J 4P6
Canada
Telephone number:
780-277-5433
Web address:
www.appliedpharma.ca/
Andrew MacIsaac, Chief Executive Officer
Applied Pharmaceutical Innovation / Applied Pharmaceutical Innovation is not a subsidiary of any other parent companies.
Applied Pharmaceutical Innovation / Applied Pharmaceutical Innovation is not a coalition.
The activities of Applied Pharmaceutical Innovation / Applied Pharmaceutical Innovation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Applied Pharmaceutical Innovation / Applied Pharmaceutical Innovation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Jon Dugal | Public offices held
Firm: New West Public Affairs / New West Public Affairs